08:30 – 10:00 hrs | Concurrent Symposia S10-14 & Educational Sessions E10-E11

Chairs:  Elfride de Baere
Room:   A6+A7

S10.1 From digenic predictions to oligogenic networks via a new predictive approach

Tom Lenaerts;
Belgium

S10.2 Common Variants Determine Quasi-Mendelian Inheritance of Rare Diseases

Carlo Rivolta;
Switzerland

S10.3 Testing the Limits of Mendelian Inheritance Through Autozygosity

Fowzan Alkuraya;
Saudi Arabia

Chairs:   Jose Luis Costa
Room:    A8

S11.1 Single-Cell RNA-Seq on Tumor Microenvironment in Lung Cancer

Bernard Thienpont;
Belgium

S11.2 Single-Cell Analysis in Tumour Progression

Alex Swarbrick;
Australia

S11.3 Single cell to understand AML progression

Alexander Perl;
United States

Chairs:  Maris Laan
Room:   A2

S12.1 Fetal Loss Caused by Genetic Defects of the Placenta

Myriam Hemberger;
Canada

S12.2 Genetics of Recurrent Hydatidiform Moles: Novel Findings and Patient Counselling

Rima Slim;
Canada

S12.3 Placental Organoids to Understand Pregnancy Disorders

Graham J. Burton;
United Kingdom

Chairs:   Francesca Forzano
Room:    A1

S13.1 The State of the Science of Human Germline Genome Editing and Ethical Concerns

Michele Ramsay;
South Africa

S13.2 Addressing Misuse of Science in Surveillance

Yves Moreau;
Belgium

S13.3 Using Direct to Consumer Test for Forensic Purposes

Amade M’charek;
The Netherlands

Chairs:   Nicola Brunetti-Pierri
Room:    A4

S14.1 The Lysosome in the Control of Cell Metabolism

Andrea Ballabio;
Italy

S14.2 Lysosomal Storage Disorders: The Attenuated Phenotypes

Carla Hollak;
The Netherlands

S14.3 Therapy of Lysosomal Storage Disorders – Lessons from Fabry Disease

Raphael Schiffmann;
United States

Chairs:   Joris Veltman
Room:    A3

E10.1 Gene therapy in genetic disorders

Marina Cavazzana;
France

E10.2 Trial readiness, trial endpoints and stakeholder collaboration

Volker Stauber;
United Kingdom

Chairs:   Zoltan Kutalik
Room:    A5

E11.1 Heritability Estimation and Gene-Environment Interactions

Alexander Young;
United Kingdom

E11.2 Flexible Heritability Estimation from Summary Statistics

Doug Speed;
Denmark

08:30 – 10:00 hrs | Corporate Satellites

More information

10:00 – 10:30 hrs | Coffee Break, Exhibition, Poster Viewing

10:30 – 12:00 hrs | Concurrent Sessions C16-C23 from submitted abstracts

12:00 – 13:00 hrs | Lunch Break, Exhibition, Poster Viewing

12:00 – 13:00 hrs | Corporate Satellites

More information

12:15 – 13:00 hrs | Plenary Session PL3

Chairs:   Sam Riedijk, Ramona Moldovan
Room:    Hall B

PL3.1  ELPAG Award Lecture

Heather Skirton;
United Kingdom

13:00 – 14:00 hrs | Poster Viewing with Authors – Group C

14:15 – 15:45 hrs | Workshops W12-W18

More information will follow in spring 2020.

More information will follow in spring 2020.

More information will follow in spring 2020.

More information will follow in spring 2020.

More information will follow in spring 2020.

More information will follow in spring 2020.

14:15 – 15:45 hrs | Corporate Satellites

More information

15:45 – 16:00 hrs | Fruit Break, Exhibition, Poster Viewing

16:00 – 17:00 hrs | Poster Viewing with Authors – Group D

17:15 – 18:45 hrs | Concurrent Symposia S15-S18 & Educational Sessions E12-E13

Chairs:  Joris Veltman, Teri Manolio
Room:   Hall B

S15.1 Polygenic risk scores in the clinic: Challenges and opportunities

Michael Inouye;
United Kingdom

S15.2 Polygenic Risk Scores, How to Use?

Marc Daly;
Finland

S15.3 Polygenic risk scores and their use in the clinic

Amit Khera;
United States

S15.4 Improving Polygenic Risk Scores for Clinical Applications

Krista Fischer;
Estonia

Chairs:  Martin Kircher
Room:   A8

S16.1 Detection of Structural Variation and Haplotype-Aware Genome Assembly

Tobias Marschall;
Germany

S16.2 Improving the Detection and Genotyping of Structural Variation

Birte Kehr;
Germany

S16.3 Annotation and Curation of High-Confidence Structural Variants

Aaron Quinlan;
United States

Chairs:  Doris Steinemann
Room:   A2

S17.1 Inherited Myeloid Malignancies

Lude Fitzgibbon;
United Kingdom

S17.2 Genetics and Mechanisms of Acute Lymphoblastic Leukemia

Adolfo Ferrando;
United States

S17.3 Somatic versus Germline Alterations in Leukemia

Cristina Mecucci;
Italy

Chairs:  Valerie Cormier-Daire
Room:   A5

S18.1 Cornelia de Lange Spectrum: does deep phenotyping help?

Feliciano Ramos;
Spain

S18.2 Genetic causes and overlapping mechanisms in the spectrum of Cornelia de Lange syndrome

Frank Kaiser;
Germany

S18.3 Post-Zygotic Mutation as a Cause of Typical Cornelia De Lange Syndrome

David FitzPatrick;
United Kingdom

Chairs:   Christian Gilissen
Room:    A3

E12.1 A Guide to Deep Learning in Healthcare

Mark DePristo;
United States

E12.2 A Guide to Deep Learning in Healthcare

Marcel Schulz;
Germany

Chairs:   Edward Dove
Room:    A1

E13.1 Mitochondrial Replacement Techniques: Identifying the Biological Consequences

Mary Herbert;
United Kingdom

E13.2 Should the UK’s Approach to MRT be Adopted in Other Countries?

César Palacios-González;
United Kingdom